A new journey of coagulation: 2024 CSTH Shanghai Sun Biotech shines brightly

  • 2024-11-26

  • Company News

From November 21th to 23th, 2024, the China Thrombosis and Hemostasis Conference was held in Changsha, jointly sponsored by the Thrombosis and Hemostasis Committee of the Chinese Society of Research Hospitals (CSTH), the Medical Inspection Industry Branch of the National Health Industry Enterprise Management Association, and the Experimental Medicine Branch. The conference brought together top experts from home and abroad to discuss the latest progress in clinical and basic research, consensus interpretation, and other fields of thrombosis and hemostasis. As an innovative pioneer in the field of coagulation testing, Shanghai Sun Biotech made a grand debut with a series of products, bringing professional coagulation testing overall solutions to clinical testing laboratories.


01. New heights in intelligent efficiency:UL-2000LAS coagulation automation system

As the focus of the conference, the UL-2000LAS coagulation assembly line has won wide attention for its excellent performance. The innovative single-tube transmission can effectively avoid sample congestion. Equipped with the UR8000 ultra-high-speed analysis module, it can achieve a single-module constant speed of 900tests/hour, the world's leading detection speed, and cope with the laboratory's high-throughput detection needs. The flexible modular design, combined with on-track sampling, HIL monitoring, automatic retesting and other designs, comprehensively improves detection efficiency and accuracy.

02. Constant speed and precise:UR6000/UP5500 coagulation analyzer

UR6000 and UP5500 coagulation analyzers adopt the international mainstream optical detection principle, have 20 full-methodological detection channels, and are equipped with HIL intelligent monitoring, multi-wavelength design and APTT automatic correction test functions to ensure its high efficiency and accuracy. The UR6000 detection speed can reach a constant speed of 450tests/hour, supports three injection methods: front injection, side injection and track injection, and combines humanized designs such as 360° automatic rotating barcode reading and cap-piercing to meet the diverse needs of laboratories of different sizes.

03. Multi-dimensional layout for the future:New coagulation diagnostic products emerge in succession

At this conference, Shanghai Sun Biotech launched a three-level, five-project composite coagulation quality control product, covering PT, APTT, TT, FIB, AT-III and other projects, which is compatible with the mainstream coagulation analyzers in the market. Complementary with the company's existing non-fixed value quality control products, it provides laboratories with diversified quality control options. Protein C detection reagents further improve the company's product layout in thrombophilia screening. In the future, Shanghai Sun Biotech will continue to deepen coagulation testing, increase R&D investment, and bring more innovative products to clinical testing.


Highlights of the conference

During the conference, the Shanghai Sun Biotech booth was crowded with people, attracting many experts and scholars to consult products and exchange technologies. Many users said that the comprehensive performance of UR6000 coagulation analyzer surprised them very much. It is not only faster than the original imported coagulation analyzer, but also greatly reduces the consumables cost of their laboratories. After a deep understanding of the product performance, many experts highly recognized the company's technological innovation capabilities and had in-depth communication on the possibility of future cooperation. The lively booth fully reflects the users' confidence and expectations for the company's products.

In the future, Shanghai Sun Biotech will continue to uphold the concept of "Creating products for life", drive development with innovation, adhere to the quality management system, continuously improve the R&D and innovation capabilities of instruments and reagents, and strive to bring more breakthrough solutions to the field of thrombosis and hemostasis diagnosis!

TOP